I-Tech expands team with Technical Director appointment I-Tech AB, the bio-technology company responsible for the unique marine anti-fouling active agent Selektope®, has appointed Dr. Markus Hoffmann to the role of…
To satisfy increasing customer demand for antifouling coatings including Selektope® in the marine market, Swedish bio-technology innovator I-Tech AB plans to evaluate an advanced European manufacturer of active pharmaceutical ingredients…
I-Tech AB, the company behind the development of the unique antifouling ingredient Selektope®, has applied for admission to trade the company’s shares on the Nasdaq First North Stockholm exchange. The…
Swedish bio-technology company I-Tech AB has today announced the strategic acquisition of manufacturing process technology and IP, for the production of medetomidine, from Cambrex Corporation (NYSE: CBM). The transaction consolidates…
I-Tech AB has been recognized as the technology innovation leader in the European marine biocides market, resulting in the company receiving the 2017 Technology Innovation Award from Frost & Sullivan.…